1955

DOI: 10.1148/64.6.858

|View full text |Cite

|

Sign up to set email alerts

|

The Treatment of Thyrotoxicosis with Radioiodine

Richard H. Chamberlain²,

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

0

Mentioning

1

Contrasting

0

Year Published

1957

1957

1972

1972

Publication Types

Select...

Article5

Book1

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 22 publications

(1 citation statement)

References 0 publications

Supporting

0

Mentioning

1

Contrasting

0

Order By: Relevance

“…RADIOACTIVE iodine is now an integral part of the therapy of thyrotoxicosis in selected cases. Since the earlier reports of the work of Balls et al (1955), Beierwaltes & Johnson (1956) and Chapman & Maloof (1955), much data has accumulated concerning the indications for, dosage of and complications following 131I therapy.…”

mentioning

confidence: 99%

Radioactive iodine (131I) therapy for thyrotoxicosis at Groote Schuur Hospital over a 6-year period

¹

,

²

,

³

et al. 1972

Postgraduate Medical Journal

View full text Add to dashboard Cite

SummaryThe case records of 262 patients who received 131l therapy during a 6-year period were analysed retrospectively. These included seventy-eight patients who received more than one therapeutic dose.The major indication for 131I therapy was thyrotoxicosis occurring in patients aged 40 years and over.

“…RADIOACTIVE iodine is now an integral part of the therapy of thyrotoxicosis in selected cases. Since the earlier reports of the work of Balls et al (1955), Beierwaltes & Johnson (1956) and Chapman & Maloof (1955), much data has accumulated concerning the indications for, dosage of and complications following 131I therapy.…”

mentioning

confidence: 99%

Radioactive iodine (131I) therapy for thyrotoxicosis at Groote Schuur Hospital over a 6-year period

¹

,

²

,

³

et al. 1972

Postgraduate Medical Journal

View full text Add to dashboard Cite

SummaryThe case records of 262 patients who received 131l therapy during a 6-year period were analysed retrospectively. These included seventy-eight patients who received more than one therapeutic dose.The major indication for 131I therapy was thyrotoxicosis occurring in patients aged 40 years and over.

Treatment of Hyperthyroidism with Individually Calculated Doses of I131

1957

Arch Intern Med

View full text Add to dashboard Cite

No abstract

Why Not Radioiodine Therapy for Toxic Nodular Goiter?

1967

Arch Intern Med

View full text Add to dashboard Cite

No abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.